Title: BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
Journal: Blood 20090813
Title: An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.
Journal: Experimental neurology 20081201
Title: Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.
Journal: Archives of ophthalmology (Chicago, Ill. : 1960) 20081201
Title: Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
Journal: The Journal of pharmacology and experimental therapeutics 20050201
Title: Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
Journal: Blood 20031215
Title: An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis.
Journal: The Journal of pharmacology and experimental therapeutics 20030601
Title: Ramirez P, et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood. 2009;114(7):1340‐1343.
Title: Leone DR, et al. An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther. 2003;305(3):1150‐1162.
